Federal Register / Vol. 76, No. 62 / Thursday, March 31, 2011 / Notices 17967 

By order of the Commission: 

Issued: March 28, 2011. 

William R. Bishop, 

Hearings and Meetings Coordinator. 

[FR Doc. 2011–7671 Filed 3–29–11; 11:15 am] 

BILLING CODE 7020–02–P 

JOINT BOARD FOR THE 

ENROLLMENT OF ACTUARIES 

Meeting of the Advisory Committee; 

Meeting 

AGENCY: Joint Board for the Enrollment 

of Actuaries. 

ACTION: Notice of Federal Advisory 

Committee meeting. 

SUMMARY: The Executive Director of the 

Joint Board for the Enrollment of 

Actuaries gives notice of a closed 

meeting of the Advisory Committee on 

Actuarial Examinations. 

DATES: The meeting will be held on 

April 29, 2011, from 8:30 a.m. to 5 p.m. 

ADDRESSES: The meeting will be held at 

Mercer, 4400 Comerica Bank Tower, 

1717 Main Street, Dallas, TX 75201. 

FOR FURTHER INFORMATION CONTACT: 

Patrick W. McDonough, Executive 

Director of the Joint Board for the 

Enrollment of Actuaries, 202–622–8225. 

SUPPLEMENTARY INFORMATION: Notice is 

hereby given that the Advisory 

Committee on Actuarial Examinations 

will meet at Mercer, 4400 Comerica 

Bank Tower, 1717 Main Street, Dallas, 

TX, on April 29, 2011, from 8:30 a.m. 

to 5 p.m. 

The purpose of the meeting is to 

discuss topics and questions that may 

be recommended for inclusion on future 

Joint Board examinations in actuarial 

mathematics, pension law and 

methodology referred to in 29 U.S.C. 

1242(a)(1)(B). 

A determination has been made as 

required by section 10(d) of the Federal 

Advisory Committee Act, 5 U.S.C. App., 

that the subject of the meeting falls 

within the exception to the open 

meeting requirement set forth in Title 5 

U.S.C. 552b(c)(9)(B), and that the public 

interest requires that such meeting be 

closed to public participation. 

Dated: March 25, 2011. 

Patrick W. McDonough, 

Executive Director, Joint Board for the 

Enrollment of Actuaries. 

[FR Doc. 2011–7518 Filed 3–30–11; 8:45 am] 

BILLING CODE 4830–01–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated October 8, 2010, and 

published in the Federal Register on 

October 20, 2010 75 FR 64744, Hospira 

Inc., 1776 North Centennial Drive, 

McPherson, Kansas 67460–1247, made 

application by renewal to the Drug 

Enforcement Administration (DEA) to 

be registered as an importer of 

Remifentanil (9739), a basic class of 

controlled substance listed in schedule 

II. 

The company plans to import 

Remifentanil for use in dosage form 

manufacturing. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a), 

and determined that the registration of 

Hospira Inc. to import the basic class of 

controlled substance is consistent with 

the public interest, and with United 

States obligations under international 

treaties, conventions, or protocols in 

effect on May 1, 1971, at this time. DEA 

has investigated Hospira Inc. to ensure 

that the company’s registration is 

consistent with the public interest. The 

investigation has included inspection 

and testing of the company’s physical 

security systems, verification of the 

company’s compliance with state and 

local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic class of controlled substance 

listed. 

Dated: March 21, 2011. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2011–7537 Filed 3–30–11; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated October 19, 2010, and 

published in the Federal Register on 

October 26, 2010, 75 FR 65658, Cody 

Laboratories Inc., 601 Yellowstone 

Avenue, Cody, Wyoming 82414–3921, 

made application by renewal to the 

Drug Enforcement Administration 

(DEA) to be registered as an importer of 

the following basic classes of controlled 

substances: 

Drug Schedule 

Raw Opium (9600) ....................... II 

Concentrate of Poppy Straw 

(9670).

II 

The company plans to import narcotic 

raw materials for manufacturing and 

further distribution to its customers. 

The company is registered with DEA as 

a manufacturer of several controlled 

substances that are manufactured from 

raw opium, poppy straw, and 

concentrate of poppy straw. 

No comments or objections have been 

received. DEA has considered the 

factors in 21 U.S.C. 823(a) and 952(a) 

and determined that the registration of 

Cody Laboratories, Inc. to import the 

basic classes of controlled substances is 

consistent with the public interest, and 

with United States obligations under 

international treaties, conventions, or 

protocols in effect on May 1, 1971. DEA 

has investigated Cody Laboratories, Inc. 

to ensure that the company’s 

registration is consistent with the public 

interest. The investigation has included 

inspection and testing of the company’s 

physical security systems, verification 

of the company’s compliance with state 

and local laws, and a review of the 

company’s background and history. 

Therefore, pursuant to 21 U.S.C. 952(a) 

and 958(a), and in accordance with 21 

CFR 1301.34, the above named company 

is granted registration as an importer of 

the basic classes of controlled 

substances listed. 

Dated: March 21, 2011. 

Joseph T. Rannazzisi, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration. 

[FR Doc. 2011–7542 Filed 3–30–11; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

Importer of Controlled Substances; 

Notice of Registration 

By Notice dated November 19, 2010, 

and published in the Federal Register 

on December 3, 2010 75 FR 75494, 

Mylan Technologies, Inc., 110 Lake 

Street, Saint Albans, Vermont 05478, 

made application by renewal to the 

Drug Enforcement Administration 

(DEA) to be registered as an importer of 

the following basic classes of controlled 

substances: 


wwoods2 on DSK1DXX6B1PROD with NOTICES